Results 141 to 150 of about 65,038 (202)

Non-ST-Segment Elevation Myocardial Infarction as the Initial Presentation of Chronic Lymphocytic Leukemia. [PDF]

JACC Case Rep
Gitte PT, Kharche M, Khedkar U.
europepmc   +1 more source

Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity. [PDF]

Cancer Res Commun
Tripathi C, Zolov S, Nguyen J, Luh F, Natarajan V, Yen Y.   +5 more
europepmc   +1 more source

IL21-STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia. [PDF]

Hemasphere
Del Prete R, Tusha V, Simon-Molas H, Gazziero VA, Nardi F, Drago R, Bartolini G, Licastro D, Malchiodi M, Mariottini C, Marotta G, Caravagna G, Bruscoli S, Eldering E, Gozzetti A, Bocchia M, Kabanova A.   +16 more
europepmc   +1 more source

Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort study. [PDF]

Front Immunol
Cohen R, Elbirt D, Nemet S, Kirzhner A, Schiller T, Khadija HA, Bezalel-Rosenberg S, Asher I, Mahlab-Guri K, Wolach O, Hofstetter L.   +10 more
europepmc   +1 more source

On the causes of hypogammaglobulinaemia in B-CLL.

Haematologica, 1982
R, Foa, F, Lauria, D, Catovsky
openaire   +1 more source

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.

Blood
Itsara A, Rogness VM, Samples L, Yuan CM, Wang HW, Ahn IE, Farooqui MZH, Tian X, Sun C, Tomasulo E, Soto S, Superata J, Bezkorovaynaya L, Hughes TE, Nierman P, Wiestner A.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Scoring System for the Classification of CD5- B CLL versus CD5+ B CLL and B PLL

Leukemia and Lymphoma, 1995
B CLL is a monoclonal proliferation of lymphocytes which express the CD5 antigen (CD5+ CLL). Rare exceptions (less than 10%) are CD5-, as are the majority of B PLL. We have studied the clinical, cytological and immunophenotypic characteristics of a series of 12 CD5-CLL and have established a score which allows the distinction between CD5+ CLL, CD5- CLL
F, Salomon-Nguyen, F, Valensi, H, Merle-Beral, G, Flandrin   +3 more
exaly   +3 more sources